Prototype therapeutic ultrasound emitting catheter for accelerating thrombolysis.
The aim of this study was to evaluate the performance of a new therapeutic ultrasound device for accelerating thrombolysis by urokinase. Artificial thrombi were produced in vitro by Chandler's loop method. Urokinase (240 IU) was added to the artificial thrombi (n = 5) before exposure to ultrasound with the new catheter-delivered device. Ultrasound (1.3 MHz) was applied with an intensity of 0.3 W/cm2 for 60 s. The degree of fibrinolysis was obtained by measurement of thrombus weight and calculated as percentages. Fibrinolysis was compared between control thrombus groups (n = 5) treated with urokinase alone or with ultrasound alone (analysis of variance, P < 0.05). Ultrasound plus urokinase (33.1 +/- 6.1% [mean +/- standard deviation]) was significantly different urokinase alone (12.3 +/- 2.4%) after 15 min of incubation. Ultrasound alone resulted in no fibrinolysis (0.9 +/- 2.5%). Ultrasound energy from the catheter-based device was sufficient to induce acceleration of fibrinolysis with urokinase.
Tachibana
K
K
First Department of Internal Medicine, Fukuoka University School of Medicine, Japan.
Tachibana
S
S
D000704:Analysis of Variance; D000818:Animals; D002404:Catheterization; D004867:Equipment Design; D008297:Male; D010960:Plasminogen Activators / Q000008:administration & dosage*; D011817:Rabbits; D015912:Thrombolytic Therapy / Q000295:instrumentation / Q000379:methods*; D013927:Thrombosis / Q000000981:diagnostic imaging* / Q000188:drug therapy; D018084:Ultrasonography, Interventional / Q000295:instrumentation*; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage*
D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator